Kamada (KMDA) Total Liabilities (2012 - 2026)

Kamada (KMDA) posted quarterly Total Liabilities of $383.0 million for Q1 2026, up 2.11% year-on-year from $375.1 million in Q1 2025, and up 1.14% on a QoQ basis from $378.7 million in Q4 2025.

Kamada (KMDA) Total Liabilities (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Total Liabilities for 13 consecutive years, with $383.0 million the latest figure, recorded in Q1 2026.

  • Quarterly Total Liabilities rose 2.11% year-over-year to $383.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $383.0 million (up 2.11% YoY) and the FY2025 annual result came in at $378.7 million, up 1.73% from the prior year.
  • Total Liabilities grew to $383.0 million in Q1 2026 per KMDA's latest filing, from $378.7 million in the prior quarter.
  • Over the last five years, Total Liabilities for KMDA reached as high as $354.9 billion in Q4 2023 and fell as low as $303.1 million in Q1 2022.
  • A 5-year average of $41.0 billion and a median of $351.2 million in 2024 frame the typical range for Total Liabilities.
  • Annual changes were most pronounced in 2023 — Total Liabilities soared 109989.99% — and 2024, when it tumbled 99.9%.
  • Year by year, Total Liabilities stood at $322.4 million in 2022, then surged by 109989.99% to $354.9 billion in 2023, then tumbled by 99.9% to $372.3 million in 2024, then advanced by 1.73% to $378.7 million in 2025, then advanced by 1.14% to $383.0 million in 2026.
  • According to Business Quant data, Total Liabilities over the past three periods registered $383.0 million, $378.7 million, and $377.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 21.48 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 31.81 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.92 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 51.53 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 813.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 13.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 22.18 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.50 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.72 Bn
10 Kamada 401.22 Mn 328.07 Mn 19.12 Mn 383.02 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 383.02 Mn
Dec 31, 2025 378.71 Mn
Sep 30, 2025 377.21 Mn
Jun 30, 2025 368.17 Mn
Mar 31, 2025 375.11 Mn
Dec 31, 2024 372.26 Mn
Sep 30, 2024 351.21 Mn
Jun 30, 2024 351.04 Mn
Mar 31, 2024 343.17 Mn
Dec 31, 2023 354.91 Bn
Sep 30, 2023 337.06 Bn
Jun 30, 2023 314.39 Mn
Mar 31, 2023 316.80 Mn
Dec 31, 2022 322.38 Mn
Sep 30, 2022 319.64 Mn
Jun 30, 2022 304.14 Mn
Mar 31, 2022 303.10 Mn
Dec 31, 2021 318.67 Mn
Sep 30, 2021 216.53 Mn
Jun 30, 2021 216.35 Mn